Researchers at the Institute of Cancer Research, London, made a breakthrough in breast cancer treatment using Car-T immunotherapy targeting endosialin-producing cells around tumor blood supply.
Researchers at the Institute of Cancer Research, London, have made a breakthrough in breast cancer treatment using Car-T immunotherapy. The treatment targets cells surrounding the tumor's blood supply, which produce a protein called endosialin, disrupting the tumor's blood supply and preventing growth or spread. This approach could lead to more effective and targeted treatments for breast cancer patients, with the researchers now working on developing the therapy further for human use.
February 28, 2024
31 Articles